Liver-associated lymphocytes expressing NK1.1 are essential for oral immune tolerance induction in a murine model. NLM AIDSLINE Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Liver-associated lymphocytes expressing NK1.1 are essential for oral immune tolerance induction in a murine model.

Hepatology. 1999 Mar;29(3):746-55. Unique Identifier : AIDSLINE MED/99162365
Trop S; Samsonov D; Gotsman I; Alper R; Diment J; Ilan Y; Liver Unit, Division of Medicine, Hadassah University Hospital,; Jerusalem, Israel.


Abstract: Oral tolerance is the induction of immunological hyporesponsiveness towards orally administered antigens. Tolerance initiation involves induction of anti-inflammatory (Th2) lymphocytes, with downregulation of pro-inflammatory (Th1) lymphocytes. The liver was previously shown to play a critical role in oral tolerance induction. The aim of the present study was to test whether liver-associated-lymphocytes expressing the NK1.1 marker (NK1.1+ LAL) are substantial for induction of oral tolerance in an experimental colitis model. Colitis was induced in C57 mice by intracolonic instillation of trinitrobenzensulfonic acid (TNBS). Mice received five oral doses of colonic proteins extracted from TNBS-colitis colonic wall. Anti-NK1.1 monoclonal antibodies were injected before tolerance induction. Colitis was assessed by standard clinical, macroscopic, and microscopic scores. Serum IFN-gamma, TGF-beta1, and IL4 levels were measured by enzyme-linked immunosorbent assay. To evaluate the role of NK1.1+ LAL in keeping the balance between immunogenic and tolerogenic subsets of cells, we tested whether peripheral lymphocytes harvested from tolerized and NK1.1-depleted nontolerized mice can adoptively transfer the tolerance into naive irradiated rats. Depletion of NK1.1+ LAL prevented immune tolerance induction in the experimental colitis model. NK1.1+ LAL-depleted nontolerized mice, disclosed severe clinical, macroscopic, and microscopic parameters of colitis. These mice had significantly lower TGF-beta1, IL4, and higher IFN-gamma serum levels, and their lymphocytes failed to transfer the tolerance into naive animals. In contrast, the feeding of colitis-extracted proteins, without NK1.1+ LAL depletion, markedly alleviated the disease. Tolerized mice had higher IL4 and TGF-beta1 and lower IFN-gamma serum levels, and adoptive transfer of their suppressor splenocytes markedly alleviated colitis in naive recipients. NK1.1+ LAL plays a critical role in oral tolerance induction. Depletion of this subset of LAL prevents a shift from Th1 to a Th2 type of immune response, hindering the ability to induce immune tolerance.
Keywords: JOURNAL ARTICLE Administration, Oral Animal Antibody Formation/PHYSIOLOGY Antigens/*ADMINISTRATION & DOSAGE/IMMUNOLOGY/*METABOLISM Biological Markers Colitis/IMMUNOLOGY/PATHOLOGY Cytokines/BLOOD Cytotoxicity, Immunologic/PHYSIOLOGY Immune Tolerance/*PHYSIOLOGY Killer Cells, Natural/*IMMUNOLOGY Liver/*CYTOLOGY Lymphocytes/IMMUNOLOGY/*METABOLISM Male Mice Mice, Inbred C57BL Proteins/IMMUNOLOGY Rats Support, Non-U.S. Gov't T-Lymphocytes, Suppressor-Effector/PHYSIOLOGY Th1 Cells/IMMUNOLOGY Th2 Cells/IMMUNOLOGYKWDjournalarticleadministration,oralanimalantibodyformation/physiologyantigens/KWDadministration&dosage/immunology/KWDmetabolismbiologicalmarkerscolitis/immunology/pathologycytokines/bloodcytotoxicity,immunologic/physiologyimmunetolerance/KWDphysiologykillercells,natural/KWDimmunologyliver/KWDcytologylymphocytes/immunology/KWDmetabolismmalemicemice,inbredc57blproteins/immunologyratssupport,non-uKWDsKWDgov'tt-lymphocytes,suppressor-effector/physiologyth1cells/immunologyth2cells/immunology
990630
A9960932

Copyright © 1999 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .